TMJ Stock Chart & Stats
€153.60
-€10.60(-6.63%)
At close: 4:00 PM EDT
€153.60
-€10.60(-6.63%)
Day’s Range― - ―
52-Week Range€112.00 - €165.30
Previous CloseN/A
Volume0.00
Average Volume (3M)7.00
Market Cap
€11.27B
Enterprise Value€17.04K
Total Cash (Recent Filing)€455.38M
Total Debt (Recent Filing)€2.94B
Price to Earnings (P/E)11.1
Beta0.13
Next Earnings
Oct 28, 2026EPS Estimate
4.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)15.22
Shares Outstanding76,849,450
10 Day Avg. Volume1
30 Day Avg. Volume7
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.89
Price to Sales (P/S)1.89
P/FCF Ratio9.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€166.51Price Target Upside8.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)13.63
Revenue Forecast (FY)€5.54B
Bulls Say, Bears Say
Bulls Say
Strong Free-cash-flow ConversionGlobe Life converts a very high proportion of earnings into free cash flow (~0.89–0.98 historically) with TTM FCF growth and operating cash flow improvement to $1.81B. Durable FCF supports buybacks, dividends, reinvestment and cushions underwriting volatility over 2–6 months.
Conservative Capital And Liquidity ProfileA 316% RBC and recent amendments extending credit facilities and increasing term-loan availability indicate strong regulatory capital and funding flexibility. This durable capital buffer supports underwriting capacity and shareholder returns while absorbing claim or market shocks.
Diversified Distribution And Steady Premium GrowthMultiple channels (agents, DTC, independent) plus strong health and United American growth drive durable top-line momentum. Consistent premium growth and solid life underwriting margins provide structural revenue stability and margin support over the medium term.
Bears Say
Direct-to-consumer Disruption From AI/search ChangesChanges in search behavior driven by AI reduce paid-search efficacy, structurally impairing a scalable DTC acquisition channel. Adapting digital content and marketing will require sustained investment and may raise acquisition costs and depress DTC sales for multiple quarters.
Elevated Health Claims And Higher Health ObligationsRising health obligations and margin compression reflect claim volatility (Medicare supplement adjustments, cancer claims, CMS corrections). Persistently higher obligations pressure underwriting profitability, capital needs and pricing, creating structural earnings volatility until trends normalize.
EVRI Startup Dragging United American MarginsThe EVRI health startup is producing early underwriting losses and lowering segment margins. Scaling will take time and capital, creating persistent near-term margin dilution and reserve pressure until EVRI achieves scale and stable loss ratios.
Globe Life News
TMJ FAQ
What was Globe Life’s price range in the past 12 months?
Globe Life lowest stock price was €112.00 and its highest was €165.30 in the past 12 months.
What is Globe Life’s market cap?
Globe Life’s market cap is €11.27B.
When is Globe Life’s upcoming earnings report date?
Globe Life’s upcoming earnings report date is Oct 28, 2026 which is in 68 days.
How were Globe Life’s earnings last quarter?
Globe Life released its earnings results on Jul 22, 2026. The company reported €3.127 earnings per share for the quarter, missing the consensus estimate of €3.181 by -€0.055.
Is Globe Life overvalued?
According to Wall Street analysts Globe Life’s price is currently Undervalued.
Does Globe Life pay dividends?
Globe Life does not currently pay dividends.
What is Globe Life’s EPS estimate?
Globe Life’s EPS estimate is 4.26.
How many shares outstanding does Globe Life have?
Globe Life has 76,849,450 shares outstanding.
What happened to Globe Life’s price movement after its last earnings report?
Globe Life reported an EPS of €3.127 in its last earnings report, missing expectations of €3.181. Following the earnings report the stock price went down -0.374%.
Which hedge fund is a major shareholder of Globe Life?
Currently, no hedge funds are holding shares in DE:TMJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Globe Life Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€166.51 (8.41% Upside)
€166.51 (8.41% Upside)
Blogger Sentiment
Bullish
DE:TMJ Sentiment 60%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €35.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.97%
12-Months-Change
Fundamentals
Return on Equity
0.72%
Trailing 12-Months
Asset Growth
5.88%
Trailing 12-Months
Company Description
Globe Life
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
TMJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong positives — double-digit GAAP and operating EPS growth, premium growth (especially in health and United American), improving investment yields and conservative portfolio positioning, an expanded share repurchase program, and upward guidance aided by expected assumption-update benefits. Counterbalancing these are execution and margin pressures: DTC sales disruption from AI-driven changes in search, a YoY decline in AIL agent count (though with sequential improvement), elevated health claims and higher health obligation ratios in Q2, and a near-term drag from the EVRI startup. Investment unrealized losses are interest-rate driven and manageable per management. On balance the company emphasized resilient operations, conservative investments, returning capital to shareholders, and clear plans to address distribution and AI-related digital changes.View all DE:TMJ earnings summariesTMJ Revenue Breakdown
56.44% Life
24.31% Health
0.00% Annuity
19.65% Investment
<0.01% Corporate & Other
-0.42% Realized gains (losses)
TMJ Stock 12 Month Forecast
Average Price Target
€166.51
▲(8.41% Upside)
Technical Analysis
Lincoln National
―
Primerica
―
Unum Group
―
Jackson Financial Incorporation
―
F&G Annuities & Life Inc
―